Objectives: High-fat high-sucrose diet (HFHS) overfeeding is one of the main factors responsible for the increased prevalence of metabolic disorders. Elevated levels of branched-chain amino acids (BCAAs) have been associated with metabolic dysfunctions, including insulin resistance (IR). The aim of this study was to elucidate whether elevated BCAA levels are the cause or the consequence of IR and to determine the mechanisms and tissues involved in such a phenotype. Methods: We performed a 2-mo follow-up on minipigs overfed an HFHS diet and focused on kinetics fasting and postprandial (PP) BCAA levels and BCAA catabolism in key tissues. Results: The study of the fasting BCAA elevation reveals that BCAA accumulation in the plasma compartment is well correlated with IR markers and body weight. Furthermore, the PP excursion of BCAA levels after the last HFHS meal was exacerbated when compared with that of the first meal, suggesting a reduced amino acid oxidation potential. Although only minor changes in BCAA metabolism were observed in liver, muscle, and the visceral adipose tissue, the oxidative deamination potential of the subcutaneous adipose tissue was blunted after 60 d of HFHS feeding. Conclusions: To our knowledge, the present results demonstrated for the first time in a swine model of obesity and IR, the existence of a phenotype related to high-circulating BCAA levels and metabolic dysregulation. The oxidative BCAA capacity reduction specifically in the subcutaneous adipose tissue emerges, at least in the present swine model, as the more plausible metabolic explanation for the elevated blood BCAA phenotype.
Introduction
The consumption of high-energy diets rich in fat, sugars, or both is increasing worldwide, paralleling the increases in obesity and metabolic diseases like type 2 diabetes mellitus and cardiovascular diseases [1] . High-fat high-sugar (HFHS) diets are highly palatable and have a poorly controlled intake [2] . Despite the high interindividual variability in the sensitivity to weight and adiposity gains, HFHS overfeeding is one of the main factors responsible for the increased prevalence of adiposity and metabolic disorders involving insulin resistance (IR) and leading to chronic metabolic diseases [3] .
Among the most recently studied metabolic dysfunctions and plasma metabolites alterations associated with IR occurrence, the place of branched-chain amino acids (BCAA) is questioned [4] . An increased level of plasma BCAA is observed in individuals who are insulin resistant and shown to be altered simultaneously with IR and diabetes installation [5] . To date, the underlying mechanisms explaining these increased BCAA levels is still under debate [6, 7] and whether the increased level of BCAA should be considered as causal of IR or a consequence of its installation remains controversial [7] . Indeed, a BCAA-altered metabolism in adipose tissue (AT) associated with a reduction of the capacity of the BCAA catabolic enzymes has been clearly shown in case of obesity-associated IR [4, 6] . However, the role of other tissues in BCAA metabolism or their metabolite production has been less studied in such situations. This is the case of the liver, which is poorly involved in BCAA transamination (BCAA → keto acids [KA]) but is a major actor in KA catabolism [8] . Finally, it is unclear whether increased BCAA results from altered AT metabolism associated with obesity or if it is the consequence of the IR development, which will ultimately lead to obesity and dysfunction of adipose cells in BCAA metabolism [4] .
Despite the fact that elevated levels of BCAAs have been repeatedly correlated to IR in human cohort studies, the data concerning the mechanisms by which BCAA would increase in plasma came mainly from rodents that were genetically modified in many cases. Additionally, little is known about the timecourse increase of BCAA, and only a few studies were focused on a longitudinal follow-up [9] . To determine whether increased circulating levels of BCAAs are at the origin of the IR phenotype, we explored the BCAA metabolism on an animal model that is close to humans, allowing the accession to repeated sampling over long periods. Therefore, we performed a 2-mo follow-up on Yucatan minipigs overfed an HFHS diet, previously shown to induce a human-like obese/IR phenotype [10] . We focused on both fasting and postprandial (PP) glucose, lipids, and BCAA metabolisms at the plasma level. BCAA catabolism was explored in key tissues at the enzyme, protein, and gene expression levels.
Materials and methods

Animals and experimental procedure
The study involved five female adult Yucatan minipigs (30 ± 1 kg). Three weeks before the experiment, minipigs were surgically fitted with a catheter in the abdominal aorta. During surgery, tissue biopsies were collected and frozen at −80°C, including liver, skeletal muscle (semimembranous), visceral (VAT), and subcutaneous (SCAT) adipose tissue. Animals were housed in subject pens in a ventilated room with controlled temperature (21°C) and regular light cycle. They were fed once daily with 400 g of a concentrate feed (Porcyprima, Sanders, France) and had free access to tap water. All procedures were approved by the Auvergne Ethical Committee (authorization 02090.01).
After the recovery period, minipigs were fed an HFHS diet consisting of a regular pig diet enriched with fat (13% palm oil) and sugar (10% sucrose; 1 kg/ d, 15.5 kJ/d) for 2 mo. A PP kinetic sampling was performed after the first (day 0) and last (day 60) meals. Blood was collected through the catheter on heparinized tubes before (0) and 60, 180, 330, and 510 min after meal ingestion. Furthermore, blood also was sampled after an overnight fast before (0), and 7, 14, 21, 30, 45, and 60 d after HFHS feeding. Blood was centrifuged at 4500 g for 10 min; plasma was collected and stored at −80°C. Body weight was determined weekly. After 2 mo, minipigs were sacrificed after an overnight fasting period and tissues collected as above.
Analytical procedures Plasma insulin, metabolite, and enzyme activities determinations
Glucose, triacylglycerol (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and urea concentrations were enzymatically measured using commercial kits on an ABX Pentra 400 (Horiba Medical, France) test system. Plasma insulin levels were assessed using a commercial enzyme-linked immunosorbent assay kit (Mercodia, Sweden). Total BCAA and α-KA levels were determined enzymatically as in [11] . Branchedchain aminotransferase 2 (BCAT2) enzyme activity was determined by following the NADH consumption at 340 nm, as done previously [12] . Protein was determined by the BCA method. The homeostatic model assessment (HOMA)2-IR, HOMA2-%B, and HOMA2-%S indices were calculated by the program HOMA Calculator v2.2.3 (http://www.dtu.ox.ac.uk/ToolsSoftware/).
Polymerase chain reaction and Western blot analyses
Total RNA was extracted using RNEasy Mini Kit (Qiagen, Gaithersburg, MD, USA) and mRNA levels were determined by reverse transcription polymerase chain reaction (RT-PCR). cDNA was generated from 1 μg RNA using high-capacity cDNA reverse transcription kit (Life Technologies, France). Real-time PCR was performed in the CFX96 Touch Real-Time PCR Detection System (BIO-RAD, Hercules, CA, USA), as previously discussed [13] . For Western blot analyses, total protein lysates (20 μg for liver, 30 μg for VAT and SCAT, and 40 μg for muscle) were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis, electrotransferred on a polyvinylidene fluoride membrane and probed with the phosphor-branched-chain α-KA dehydrogenase (pBCKDH)-α at serine 293 antibody (Abcam, Cambridge, UK). Bands were visualized by infrared fluorescence using the Odyssey imaging system. The signal of each protein was normalized to the glyceraldehyde-3-phosphate dehydrogenase (muscle, liver; Sigma, Raleigh, NC, USA) and β-actin (VAT, SCAT; Cell Signaling Technology, Beverly, MA, USA) signal.
Statistical analyses
The differences between groups were analyzed using a repeated-measures one-way analysis of variance (ANOVA) test for the fasting data and a repeatedmeasures two-way ANOVA test (time and diet as variables) for the PP data, followed by post hoc Holm-Sidak comparison for the kinetics comparison, and a t test for the day 0 versus day 60 comparisons (SigmaPlot 12, Systat Software, San Jose, CA, USA). The P value significance threshold was set at <0.05. Table 1 presents the metabolic phenotype of obese minipigs. After 60 d of HFHS feeding, minipigs not only showed an increased body weight (+45%), but also a perturbed glucose homeostasis, with higher insulin levels (about +2-fold), HOMA-IR (+5.5-fold), and HOMA-%B (2-fold) indices and a reduced HOMA-%S index (−2-fold). Other metabolisms also were affected, as shown by increased TC (+1.4-fold) and HDL-C (+1.5-fold) levels, and reduced urea levels (−1.3-fold).
Results
BCAA and KA levels in plasma are shown in Figure 1 . We observed that BCAA levels increased in two steps, with similar levels between days 0 and 7, and then increased at day 14, which remained steadily elevated to the end of the trial. The plasma KA profile followed a similar trend. However, we did not observe the two steps in the kinetics; KA levels increased progressively up to day 60. The PP BCAA profile also showed that BCAA handling was different after 60 d of HFHS feeding. Not only was the basal level higher in the HFHS-fed minipigs, but the entire profile after the meal was higher than after a regular meal, especially during the first 3 h.
Liver BCAA metabolism is represented in Figure 2 . The BCAA metabolism was differentially regulated by HFHS feeding according to the different steps of their catabolism. The transamination potential was reduced by the HFHS diet, with a twofold reduction in bcat2 mRNA levels and 21-fold diminution in BCAT activity. Concerning the oxidative deamination, although no changes were observed in the pBCKDH complex, the mRNA levels of some of its subunits were significantly reduced (30 to 40%), including bckdha, dbt, dld. The BCAA metabolism in the AT is shown in Figure 3 . In VAT, despite the absence of changes in the pBCKDH status, BCAT2 activity was enhanced by the HFHS feeding by 15-fold. A smaller (fivefold) but significant increase in BCAT2 activity also was observed in SCAT, accompanied by a 50% increase in the pBCKDH complex and the mRNA levels of dld (P = 0.092).
Finally, we explored the skeletal muscle BCAA metabolism (Fig. 4) . We noticed only a few changes in BCAA metabolism induced by the HFHS diet, including a 50% increase in the mRNA levels of bckdk and a 40% increase in BCAT activity and mRNA levels.
Spearman correlations between fasting and PP (0 → 510 min after the meal) BCAA levels and variables related to glucose and lipid homeostasis are shown in Table 2 . Two clear and different correlation patterns were observed. First, fasting BCAA levels significantly correlated with variables related to glucose homeostasis, including HOMA-IR (r = 0.46), HOMA2-%B (r = 0.46), HOMA2-%S (r = −0.46), fasting plasma glucose (r = −0.65), and insulin (r = 0.54) levels, although only fasting glucose (r = 0.74) correlated with the PP BCAA levels. In contrast to the fasting BCAA, PP BCAA area under the curve (AUC) correlated with biochemical variables related to dyslipidemia, including fasting TGs (r = 0.69), TC (r = 0.95), and HDL-C (r = 0.93). Finally, we found a strong correlation of body weight with both fasting (r = 0.71) and PP (r = 0.91) BCAA levels. We also performed correlations between the major variable related to BCAA catabolism altered in the present study (pBCKDH in SCAT) and glucose and lipid homeostasis biomarkers (Table 3) . SCAT pBCKDH correlated positively with both fasting (r = 0.77) and PP (r = 0.76) plasma BCAA levels, and also with body weight (r = 0.77) and two markers of dyslipidemia: fasting TC (r = 0.73) and HDL-C (r = 0.71).
Finally, we found a correlation between PP BCAA and urea-level excursions after the meal (Fig. 5) . A good positive correlation was found between both parameters but only ) and mRNA levels (bckdha, bckdhb, dld, dbd) in the liver of Yucatan minipigs fed an HFHS diet over 2 mo. BCAT2, branched-chain aminotransferase 2; BCKDH, branched-chain α-keto acid dehydrogenase; HFHS, high-fat high-sucrose. Data presented as mean ± SEM (n = 4-5). *Significant (P < 0.05) differences between day 0 and day 60. after the first HFHS meal at day 0 (r = 0.615; P = 0.001). In contrast, after 2 mo of HFHS feeding, the variables were no longer correlated (r = −0.048; P = 0.836). Furthermore, no correlation was found between fasting BCAA and urea (data not shown).
Discussion
The present study explored the BCAA metabolism in selected tissues of HFHS-fed minipigs. To our knowledge, this was the first time that a time-course follow-up of BCAA and KA levels Fig. 3 . BCAT2 activity and mRNA levels (bcat2), BCKDH complex phosphorylation status (Ser 293 ) and mRNA levels (bckdha, dld) and branched-chain keto acid dehydrogenase kinase (bckdk) in the visceral and subcutaneous adipose tissues of Yucatan minipigs fed an HFHS over 2 mo. BCAT2, branched-chain aminotransferase 2; BCKDH, branched-chain α-keto acid dehydrogenase; HFHS, high-fat high-sucrose. Data presented as mean ± SEM (n = 4-5). *Significant (P < 0.05) differences between day 0 and day 60. was performed in a swine model at the onset of obesity and IR installation. Observations from the present study revealed increased BCAA accumulation in blood regardless of the feeding status (fasted or fed), with particularly exacerbated PP BCAA excursion after 2 mo of HFHS feeding. This profile was associated with minor changes in BCAA catabolism in liver, VAT, and skeletal muscle despite changes in their transamination capacities. In contrast, an important reduction in BCAA catabolism was noticed in SCAT, which could at least in part explain the elevated BCAA profile in blood.
Elevated blood BCAA levels are a common feature of a developed pathophysiological state characterized by obesity and IR [4] . It has been suggested that this profile is part of a panel of biomarkers able to predict the onset of more severe complications like diabetes in humans [14] . In the present study, we observed that after 2 mo of HFHS feeding, the BCAA augmentation at the fasting state was visible only after 14 d, reaching statistical significance at 1 mo. After this period, blood BCAA levels remained stable to the end of the trial. A similar profile was obtained for KA. After 2 mo of HFHS feeding, minipigs became obese with a marked hyperinsulinemia, increased HOMA-IR and dyslipidemia, and displayed elevated blood BCAA and KA levels. The fact that TG levels did not change and HDL levels were Fig. 4 . BCAT2 activity and mRNA levels (bcat2), BCKDH complex phosphorylation status (Ser 293 ) and mRNA levels (bckdha, dld) and branched chain keto acid dehydrogenase kinase (bckdk) in skeletal muscle of Yucatan minipigs fed an HFHS diet over 2 mo. BCAT2, branched-chain aminotransferase 2; BCKDH, branched-chain α-keto acid dehydrogenase; HFHS, high-fat high-sucrose. Data presented as mean ± SEM (n = 4-5). *Significant (P < 0.05) differences between day 0 and day 60.
Table 3
Results from the Spearman correlations between the phosphorylation status of the SCAT BCKDH complex (pBCKDH) and several morphologic and biochemical parameters before (day 0) and after (day 60) 2 mo of high-fat high-sucrose feeding in Yucatan minipigs SCAT pBCKDH levels (AU) increased after this period supports the idea that minipigs were at an early stage of metabolic syndrome onset, as shown in previous studies [15] , where both parameters increased after longer exposure to similar diets. Of note, we found that fasting BCAA levels were correlated with body weight, in accordance with a recent study in a human cohort [16] .
Fasting metabolism of BCAA and relation to the IR phenotype
As explained previously, we observed for the first time a progressive increase in blood BCAA levels in a swine model of dietaryinduced obesity and IR. After 2 mo of HFHS feeding, BCAA metabolism was explored in key tissues known to be important in BCAA catabolism (liver, skeletal muscle) and the in AT.
The modifications induced by 2-mo of HFHS feeding on the hepatic BCAA metabolism were overall minor. In the liver, a reduced activity and mRNA levels of the first step of BCAA metabolism (transamination) was observed, followed by a reduction in gene expression of some of the subunits of the BCKDH complex. This could lead one to determine that the already minor catabolism of BCAA in the liver [17] was further reduced. However, the phosphorylation status of the BCKDH complex remained unaltered, suggesting that the contribution of the hepatic BCAA and KA metabolism to their elevation would be negligible in the present swine model. Results of the present study are in opposition to those reported in obese rodents, where the opposite trend was observed. However, this feature was only observed in animals with a genetic background modified (ob/ob mice, Zucker rat) [7] . The available data from nonhuman primates and humans available [18] confirm our results. In the first case, after 1.5 y of HF feeding, no alteration of the complex phosphorylation was observed, whereas in obese women the phosphorylation status of the complex remained unaltered, as in our female minipigs.
Similar to the results obtained at the hepatic level, the exploration of the skeletal muscle BCAA metabolism suggests that this tissue would play only a minor role in the elevated BCAA levels in HFHS-fed minipigs. Only the transamination was affected by the diet, whereas the oxidative deamination did not confirm this trend, as previously shown in other animal models [7] and in line with the low capacity of this tissue to oxidize BCAA in nonobese animals. This does not mean that the muscle metabolism was not altered, as other studies showed that BCAA oxidation defects could participate to IR [19, 20] , but at least in the present study it does not yet seem to be visible.
Perhaps one of the most explored hypotheses aiming at explaining the elevated BCAA levels in obesity is the role of AT [4] . Both gene expression and protein concentration of enzymes involved in BCAA catabolism have been shown repeatedly to be blunted on VAT of obese individuals [21] and animal models [7, 22] , at least those genetically modified. In the present study, the BCAA transamination capacity of VAT and SCAT increased significantly with the obesity phenotype induced by the HFHS. However, the phosphorylation of the BCKDH complex was increased only in SCAT, suggesting a reduced oxidative capacity. In contrast to what has been described in rodents [23] , the present results suggest for the first time the existence of a SCAT-specific regulation. This discordance with other species might be explained by the fact that in humans, increased VAT deposition is associated with an increased risk for IR and although SCAT is associated with improved or preserved insulin sensitivity, and mitigated risk for developing type 2 diabetes and other metabolic derangements [24] . In contrast, the major site of fat deposition in the pig is in SCAT [25] . It has been suggested that SCAT accumulation could be relatively beneficial by acting as a sink, and then buffering the daily influx of nutrients by providing long-term energy storage, thereby protecting against ectopic fat deposition and associated lipotoxicity [24] . However, although in pigs SCAT seems to develop rapidly in contrast to VAT, the protective role does not seem to apply to the BCAA metabolism. In the present study, SCAT is actually the only variable showing a differential regulation of the BCKDH complex, that could explain the elevated blood BCAA levels. Taking into account that 2 mo of HFHS feeding may lead to a sevenfold increase in SCAT [10] , a reduction in BCKDH activity could have important systemic consequences. In this sense, we noticed that the phosphorylation levels of the SCAT BCKDH complex was positively correlated with both fasting and PP blood BCAA levels, suggesting that the circulating BCAA levels accurately reflect the SCAT capacity to oxidize these AA. Further support for such association was found in the strong correlation of the pBCKDH status and body weight, which in the present protocol (adult animals) likely correspond to the fat accretion. As a whole, our data collected from fat tissues confirms the captivity of the minipig AT to catabolize circulating BCAA and modulate their levels, as shown in rodents and humans [21, 26] .
Postprandial BCAA metabolism and HFHS feeding
Recently, it was shown that the PP handling and metabolism of BCAA in healthy humans should not be ignored, as it could explain the increased blood augmentation in BCAA levels. Ottosson et al. explored the PP response in BCAA and other AAs after a complex meal, and reported that the AUC of these AAs was correlated with the overnight fasting glycemia and HOMA-IR [27] . In the present study, we observed both increased fasting BCAA levels at baseline (after 60 d of HFHS feeding), and a more important AUC after the HFHS meal. Importantly, minipigs consumed the same amount of protein during the meal challenge, highlighting the importance of evaluating the PP BCAA metabolism and allowing us to hypothesize about a possible default of BCAA handling after a HFHS meal. In this sense, we found that the PP BCAA profile correlated with the urea excursions, but only at day 0, whereas no further association was found by the last meal. This suggests a direct and dynamic link between these parameters, evidencing of a default/reduction of AA catabolism following the chronic HFHS feeding that could result in increased BCAA levels. Furthermore, we found that the AUC for the PP BCAA excursion was significantly correlated with several features characterizing the long-term phenotype, including those related to obesity, such as body weight, fasting TG, and cholesterol, and those related to glucose homeostasis, such as fasting glucose levels. These correlations suggest that the perturbed handling of BCAA after an HFHS meal may be related to an obesity-prone phenotype and the onset of an impaired glucose homeostasis. In the latter case, only an impaired fasting glucose profile was significantly correlated, whereas the other correlations with IR markers (fasting insulin levels or HOMA-IR and HOMA-%B) remained as a trend (P < 0.1).
Conclusions
Overall, the results from the present study demonstrate to our knowledge, for the first time in a swine model of obesity and IR, the existence of a phenotype related to high-circulating BCAA levels and metabolic dysregulation. This is further illustrated by two sets of original data, including the time-course follow-up of the BCAA and KA levels during 2 mo of HFHS feeding and the exploration of the PP BCAA metabolism. We demonstrated that PP BCAA levels showed an exacerbated response to the HFHS meal, and this could be related to a reduced AA oxidation capacity. Furthermore, the PP profile in HFHS animals was correlated with several parameters involved in glucose homeostasis, suggesting that the exploration of the PP BCAA handling could be an interesting approach to reveal early perturbations on BCAA metabolism during obesity and IR onset. Our kinetics study of the fasting BCAA elevation during the 2 mo of HFHS reveals that BCAA accumulation in the plasma compartment is well correlated with IR markers and body weight accretion. Furthermore, the oxidative BCAA capacity was specifically reduced in SCAT and emerged, at least in the present swine model, as a more plausible metabolic explanation of such phenotype.
